Phibro Animal Health (PAHC) Revenue (2012 - 2026)

Phibro Animal Health has reported Revenue for 15 years, with the latest figure at $396.7 million in Q2 2026.

• On a quarterly basis, Revenue rose 4.77% year-over-year to $396.7 million in Q2 2026; TTM through Jun 2026 was $1.5 billion, a 17.12% increase from a year earlier, with the FY2026 full-year figure at $1.5 billion, up 17.12% from the prior year.
• Revenue was $396.7 million for Q2 2026 at Phibro Animal Health, up from $383.5 million in the prior quarter.
• The five-year high for Revenue was $396.7 million in Q2 2026, with the low at $231.3 million in Q3 2023.
• Average Revenue over 5 years is $294.7 million, with a median of $261.8 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Revenue fell 0.5% in 2023, then soared 39.73% in 2025.
• Over 5 years, Revenue stood at $244.6 million in 2022, then gained by 2.17% to $249.9 million in 2023, then climbed by 23.73% to $309.3 million in 2024, then climbed by 20.9% to $373.9 million in 2025, then grew by 6.11% to $396.7 million in 2026.
• The last three Revenue figures came in at $396.7 million (Q2 2026), $383.5 million (Q1 2026), and $373.9 million (Q4 2025), per Business Quant data.